Top advances of the year: Gastroesophageal cancer Editorial
| Authors: | Goodman, K. A.; Hotca, A.; Liu, M.; Strong, V. E.; Ilson, D. H. |
| Title: | Top advances of the year: Gastroesophageal cancer |
| Keywords: | overall survival; systemic therapy; note; capecitabine; adjuvant therapy; lymph node dissection; progression free survival; quality of life; pathology; docetaxel; gastrectomy; stomach cancer; neoadjuvant chemotherapy; oxaliplatin; esophagus cancer; stomach neoplasms; therapy; esophagus tumor; esophageal neoplasms; stomach tumor; randomized controlled trial (topic); gastroesophageal cancer; neoadjuvant chemoradiotherapy; immune checkpoint inhibitor; neoadjuvant chemoradiation; nivolumab; humans; human; non-operative management; pembrolizumab; timing of surgery; zolbetuximab |
| Journal Title: | Cancer |
| Volume: | 130 |
| Issue: | 13 |
| ISSN: | 0008-543X |
| Publisher: | Wiley Blackwell |
| Date Published: | 2024-07-01 |
| Start Page: | 2253 |
| End Page: | 2256 |
| Language: | English |
| DOI: | 10.1002/cncr.35309 |
| PUBMED: | 38578983 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Note -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
